Met Life Investment Management, LLC Viking Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $14.7 Billion
  • Q1 2024

A detailed history of Met Life Investment Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 52,198 shares of VKTX stock, worth $2.77 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
52,198
Holding current value
$2.77 Million
% of portfolio
0.03%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.4 - $94.5 $908,245 - $4.93 Million
52,198 New
52,198 $4.28 Million
Q3 2023

May 09, 2024
BUY
$10.92 - $16.0 $553,611 - $811,152
50,697 New
50,697 $561,000
Q2 2023

Apr 29, 2024
BUY
$14.84 - $24.79 $752,343 - $1.26 Million
50,697 New
50,697 $821,000
Q2 2023

Aug 10, 2023
BUY
$14.84 - $24.79 $752,343 - $1.26 Million
50,697 New
50,697 $821,000
Q2 2022

Aug 11, 2022
SELL
$2.11 - $3.15 $14,854 - $22,176
-7,040 Closed
0 $0
Q1 2022

May 10, 2024
BUY
$3.0 - $4.88 $21,120 - $34,355
7,040 New
7,040 $21,000
Q1 2022

Jun 20, 2023
BUY
$3.0 - $4.88 $21,120 - $34,355
7,040 New
7,040 $21,000
Q1 2022

Mar 22, 2023
SELL
$3.0 - $4.88 $58,311 - $94,852
-19,437 Reduced 73.41%
7,040 $21,000
Q1 2022

May 12, 2022
SELL
$3.0 - $4.88 $58,311 - $94,852
-19,437 Reduced 73.41%
7,040 $21,000
Q4 2021

May 17, 2024
BUY
$4.6 - $6.72 $52,688 - $76,970
11,454 Added 76.24%
26,477 $121,000
Q4 2021

Jun 21, 2023
BUY
$4.6 - $6.72 $121,794 - $177,925
26,477 New
26,477 $121,000
Q4 2021

Mar 22, 2023
BUY
$4.6 - $6.72 $52,688 - $76,970
11,454 Added 76.24%
26,477 $121,000
Q4 2021

Feb 15, 2022
BUY
$4.6 - $6.72 $52,688 - $76,970
11,454 Added 76.24%
26,477 $122,000
Q3 2021

May 17, 2024
SELL
$5.58 - $7.04 $69,744 - $87,992
-12,499 Reduced 45.41%
15,023 $94,000
Q3 2021

Jun 21, 2023
BUY
$5.58 - $7.04 $83,828 - $105,761
15,023 New
15,023 $94,000
Q3 2021

Mar 22, 2023
SELL
$5.58 - $7.04 $69,744 - $87,992
-12,499 Reduced 45.41%
15,023 $94,000
Q3 2021

Nov 15, 2021
SELL
$5.58 - $7.04 $69,744 - $87,992
-12,499 Reduced 45.41%
15,023 $94,000
Q2 2021

May 17, 2024
BUY
$5.19 - $6.73 $95,371 - $123,670
18,376 Added 200.92%
27,522 $164,000
Q2 2021

Jun 21, 2023
BUY
$5.19 - $6.73 $142,839 - $185,223
27,522 New
27,522 $164,000
Q2 2021

Mar 22, 2023
BUY
$5.19 - $6.73 $95,371 - $123,670
18,376 Added 200.92%
27,522 $164,000
Q2 2021

Aug 16, 2021
BUY
$5.19 - $6.73 $95,371 - $123,670
18,376 Added 200.92%
27,522 $165,000
Q1 2021

May 17, 2024
SELL
$5.74 - $9.67 $247,118 - $416,312
-43,052 Reduced 82.48%
9,146 $57,000
Q1 2021

Jun 26, 2023
BUY
$5.74 - $9.67 $52,498 - $88,441
9,146 New
9,146 $57.8 Million
Q1 2021

Mar 22, 2023
SELL
$5.74 - $9.67 $118,634 - $199,859
-20,668 Reduced 69.32%
9,146 $57,000
Q1 2021

May 14, 2021
SELL
$5.74 - $9.67 $118,634 - $199,859
-20,668 Reduced 69.32%
9,146 $58,000
Q4 2020

May 24, 2024
BUY
$5.3 - $6.71 $6,423 - $8,132
1,212 Added 4.24%
29,814 $167,000
Q4 2020

Jun 22, 2023
BUY
$5.3 - $6.71 $158,014 - $200,051
29,814 New
29,814 $167,000
Q4 2020

Mar 22, 2023
BUY
$5.3 - $6.71 $6,423 - $8,132
1,212 Added 4.24%
29,814 $167,000
Q4 2020

Feb 16, 2021
BUY
$5.3 - $6.71 $6,423 - $8,132
1,212 Added 4.24%
29,814 $168,000
Q3 2020

Jun 26, 2023
BUY
$5.73 - $8.11 $163,889 - $231,962
28,602 New
28,602 $166,000
Q2 2020

May 24, 2024
SELL
$4.35 - $8.08 $102,642 - $190,655
-23,596 Reduced 45.2%
28,602 $206 Million
Q2 2020

Jun 26, 2023
BUY
$4.35 - $8.08 $124,418 - $231,104
28,602 New
28,602 $206,000
Q1 2020

Jul 12, 2023
BUY
$3.45 - $7.95 $98,676 - $227,385
28,602 New
28,602 $133,000
Q4 2019

Jul 12, 2023
BUY
$6.38 - $8.73 $182,480 - $249,695
28,602 New
28,602 $229,000
Q3 2019

Jul 12, 2023
BUY
$6.55 - $8.6 $187,343 - $245,977
28,602 New
28,602 $196,000
Q2 2019

Jul 12, 2023
BUY
$7.67 - $10.63 $219,377 - $304,039
28,602 New
28,602 $237,000
Q1 2019

Jul 13, 2023
BUY
$7.58 - $9.94 $216,803 - $284,303
28,602 New
28,602 $284,000
Q4 2018

Jul 13, 2023
BUY
$7.16 - $16.21 $204,790 - $463,638
28,602 New
28,602 $218,000
Q4 2018

Mar 22, 2023
SELL
$7.16 - $16.21 $36,243 - $82,055
-5,062 Reduced 15.04%
28,602 $218,000
Q4 2018

Feb 14, 2019
SELL
$7.16 - $16.21 $36,243 - $82,055
-5,062 Reduced 15.04%
28,602 $219,000
Q3 2018

Jul 13, 2023
BUY
$9.7 - $19.65 $210,460 - $426,346
21,697 New
21,697 $377,000
Q3 2018

Mar 22, 2023
BUY
$9.7 - $19.65 $326,540 - $661,497
33,664 New
33,664 $586,000
Q3 2018

Nov 14, 2018
BUY
$9.7 - $19.65 $116,079 - $235,151
11,967 Added 55.16%
33,664 $586,000
Q2 2018

Aug 15, 2018
BUY
$3.88 - $12.74 $84,184 - $276,419
21,697 New
21,697 $206,000

Others Institutions Holding VKTX

# of Institutions
426
Shares Held
63.1M
Call Options Held
7.39M
Put Options Held
5.13M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.07B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email